Cannabinoid-based drug development

Cannabinoids are gaining traction in the therapeutic space, offering potential benefits beyond their current approved uses in epilepsy, multiple sclerosis, and chemotherapy-induced nausea. Emerging research highlights their promise in pain management and treating central nervous system disorders related to stress and anxiety. This whitepaper explores the growing body of science behind cannabinoid-based medicines, guiding stakeholders through the complexities of drug development in this rapidly evolving field—from selecting the right active ingredients to enhancing patient compliance. Download to learn more about navigating cannabinoid innovation and maximizing therapeutic potential.